Literature DB >> 25015114

Racial and insurance based disparities in the treatment of carotid artery stenosis: a study of the Nationwide Inpatient Sample.

Waleed Brinjikji1, Abdulrahman M El-Sayed1, David F Kallmes2, Giuseppe Lanzino3, Harry J Cloft3.   

Abstract

BACKGROUND AND
PURPOSE: Minorities and uninsured/underinsured patients have poorer access to healthcare system resources, especially preventative treatments. We sought to determine whether racial and insurance based disparities existed in the treatment of carotid artery stenosis.
METHODS: Using the Nationwide Inpatient Sample, hospitalizations for carotid artery stenting and carotid endarterectomy for symptomatic and asymptomatic carotid artery stenosis from 2005 to 2011 were identified. We calculated χ(2) tests, and bivariate and multivariable logistic regression models were fit to assess differences in the characteristics of patients receiving carotid revascularization for asymptomatic compared with symptomatic carotid artery stenosis. Demographic characteristics studied included race/ethnicity (white, black, Hispanic, Asian/Pacific Islander) and primary payer status (Medicare, Medicaid, private insurance, self-pay and no charge).
RESULTS: Between 2005 and 2011, 890 680 patients underwent carotid revascularization for the treatment of carotid artery stenosis (92.1% asymptomatic and 7.9% symptomatic). Multivariate logistic regression analysis demonstrated that Medicaid (OR=0.87, 95% CI 0.83 to 0.92, p<0.0001) and self-pay patients (OR=0.48, 95% CI 0.45 to 0.51, p<0.0001) had a lower odds of being revascularized for asymptomatic carotid artery stenosis compared with private insurance patients. Black (OR=0.81, 95% CI -0.77 to 0.84, p<0.0001) and Hispanic (OR=0.86, 95% CI -0.83 to 0.90, p<0.0001) patients had significantly lower odds of revascularization for asymptomatic carotid artery stenosis compared with white patients.
CONCLUSIONS: Minorities and self-pay/Medicaid patients were less likely to receive carotid revascularization when asymptomatic-rather they were more likely to have treatment only after symptoms had developed. These findings suggest possible disparities in the degree of morbidity related to carotid artery stenosis, the likelihood of early detection, and/or the likelihood of treatment conditional on indication. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Economics; Stent; Stroke

Mesh:

Year:  2014        PMID: 25015114     DOI: 10.1136/neurintsurg-2014-011294

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  10 in total

1.  Lower carotid revascularization rates after stroke in racial/ethnic minority-serving US hospitals.

Authors:  Roland Faigle; Lisa A Cooper; Rebecca F Gottesman
Journal:  Neurology       Date:  2019-05-17       Impact factor: 9.910

2.  Readmissions after carotid artery revascularization in the Medicare population.

Authors:  Mohammed Salim Al-Damluji; Kumar Dharmarajan; Weiwei Zhang; Lori L Geary; Erik Stilp; Alan Dardik; Carlos Mena-Hurtado; Jeptha P Curtis
Journal:  J Am Coll Cardiol       Date:  2015-04-14       Impact factor: 24.094

3.  Race as a predictor of delay from diagnosis to endarterectomy in clinically significant carotid stenosis.

Authors:  Eric S Wise; Travis R Ladner; Jun Song; Susan S Eagle; J Mocco; Justine E Wergin; Kyle M Hocking; Colleen M Brophy
Journal:  J Vasc Surg       Date:  2015-03-14       Impact factor: 4.268

Review 4.  Carotid artery stenosis screening: where are we now?

Authors:  Rebecca Mortimer; Subramanian Nachiappan; David C Howlett
Journal:  Br J Radiol       Date:  2018-06-11       Impact factor: 3.039

5.  Challenge and Yield of Enrolling Racially and Ethnically Diverse Patient Populations in Low Event Rate Clinical Trials.

Authors:  Alice J Sheffet; George Howard; Albert Sam; Zafar Jamil; Fred Weaver; David Chiu; Jenifer H Voeks; Virginia J Howard; Susan E Hughes; Linda Flaxman; Mary E Longbottom; Thomas G Brott
Journal:  Stroke       Date:  2017-11-30       Impact factor: 7.914

6.  Contemporary Trends in Physician Utilization Rates of CEA and CAS for Asymptomatic Carotid Stenosis among Medicare Beneficiaries.

Authors:  Rebecca Sorber; Michael S Clemens; Peiqi Wang; Martin A Makary; Caitlin W Hicks
Journal:  Ann Vasc Surg       Date:  2020-09-03       Impact factor: 1.466

Review 7.  Management of Patients with Asymptomatic Carotid Stenosis May Need to Be Individualized: A Multidisciplinary Call for Action.

Authors:  Kosmas I Paraskevas; Dimitri P Mikhailidis; Hediyeh Baradaran; Alun H Davies; Hans-Henning Eckstein; Gianluca Faggioli; Jose Fernandes E Fernandes; Ajay Gupta; Mateja K Jezovnik; Stavros K Kakkos; Niki Katsiki; M Eline Kooi; Gaetano Lanza; Christos D Liapis; Ian M Loftus; Antoine Millon; Andrew N Nicolaides; Pavel Poredos; Rodolfo Pini; Jean-Baptiste Ricco; Tatjana Rundek; Luca Saba; Francesco Spinelli; Francesco Stilo; Sherif Sultan; Clark J Zeebregts; Seemant Chaturvedi
Journal:  J Stroke       Date:  2021-05-31       Impact factor: 6.967

8.  Strengthened through Diversity: A Blueprint for Organizational Change.

Authors:  Allison Willis; Lesli E Skolarus; Roland Faigle; Uma Menon; Hannah Redwine; Amanda M Brown; Elizabeth Felton; Adys Mendizabal; Avindra Nath; Frances Jensen; Justin C McArthur
Journal:  Ann Neurol       Date:  2021-08-05       Impact factor: 11.274

9.  Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation.

Authors:  Yogita M Rochlani; Nishi N Shah; Naga V Pothineni; Hakan Paydak
Journal:  Cardiol Res Pract       Date:  2016-02-07       Impact factor: 1.866

10.  Accurate classification of carotid endarterectomy indication using physician claims and hospital discharge data.

Authors:  Stephen van Gaal; Arshia Alimohammadi; Amy Y X Yu; Mohammad Ehsanul Karim; Wei Zhang; Jason M Sutherland
Journal:  BMC Health Serv Res       Date:  2022-03-22       Impact factor: 2.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.